Current status of pulmonary arterial hypertension in Korea
Pulmonary arterial hypertension (PAH) is characterized by remodeling of the distal pulmonary arteries resulting in high pulmonary vascular resistance and, eventually, right ventricular heart failure. Although current advances in PAH therapy have improved outcomes, poor survival remains a reality wor...
Main Authors: | Albert Youngwoo Jang, Wook-Jin Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Association of Internal Medicine
2019-07-01
|
Series: | The Korean Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.kjim.org/upload/pdf/kjim-2019-185.pdf |
Similar Items
-
A Nationwide multicenter registry and biobank program for deep phenotyping of idiopathic and hereditary pulmonary arterial hypertension in Korea: the PAH platform for deep phenotyping in Korean subjects (PHOENIKS) cohort
by: Albert Youngwoo Jang, et al.
Published: (2019-09-01) -
Pulmonary arterial hypertension: diagnosis and treatment
by: Marcin Sadowski, et al.
Published: (2013-10-01) -
Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension)
by: E. L. Trisvetova, et al.
Published: (2016-03-01) -
Early Recognition and Management of Pulmonary Arterial Hypertension: ACase for Profiling
by: Ghulam Saydain, et al.
Published: (2012-01-01) -
Structure of therapy and compliance of patients with severe arterial hypertension
by: Aigerim Mussina, et al.
Published: (2017-06-01)